sunitinib silver 25 mg capsulas duras efg, 28 capsulas
sunitinib silver 12,5 mg capsulas duras efg, 30 capsulas
sunitinib silver 12,5 mg capsulas duras efg, 28 capsulas
sunitinib silver 50 mg capsulas duras efg, 30 capsulas
sunitinib silver 50 mg capsulas duras efg, 28 capsulas
lextemy
mylan ire healthcare limited - bevacizumab - colorectal neoplasms; breast neoplasms; ovarian neoplasms; fallopian tube neoplasms; peritoneal neoplasms; carcinoma, non-small-cell lung; carcinoma, renal cell; uterine cervical neoplasms - agentes antineoplásicos - treatment of carcinoma of the colon or rectum, breast cancer, non-small cell lung cancer, renal cell cancer, epithelial ovarian, fallopian tube or primary peritoneal cancer, and carcinoma of the cervix.
sutent 12,5 mg capsulas
pfizer venezuela, s.a. - sunitinib - capsulas - 12,5 mg
sutent 25 mg capsulas
pfizer venezuela, s.a. - sunitinib - capsulas - 25 mg
sutent 50 mg capsulas
pfizer venezuela, s.a. - sunitinib - capsulas - 50 mg
sutent cápsulas 37,5 mg
pfizer chile s.a. - sunitinib - sin formulas